Editorial
doi: 10.1160/TH10-01-0080.
Epub 2010 Feb 19.
Facts and artefacts of coagulation assays for factor Xa inhibitors
- PMID: 20174751
- DOI: 10.1160/TH10-01-0080
Item in Clipboard
Editorial
Facts and artefacts of coagulation assays for factor Xa inhibitors
Thromb Haemost.
2010 Apr.
No abstract available
Comment on
-
Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.Thromb Haemost. 2010 Apr;103(4):815-25. doi: 10.1160/TH09-03-0176. Epub 2010 Feb 2. Thromb Haemost. 2010. PMID: 20135059
Similar articles
-
Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.Thromb Haemost. 2010 Apr;103(4):815-25. doi: 10.1160/TH09-03-0176. Epub 2010 Feb 2. Thromb Haemost. 2010. PMID: 20135059
-
An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma.Thromb Haemost. 2010 Nov;104(5):1078-9. doi: 10.1160/TH10-03-0204. Epub 2010 Aug 30. Thromb Haemost. 2010. PMID: 20806114 No abstract available.
-
Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay.Thromb Haemost. 2010 Dec;104(6):1263-71. doi: 10.1160/TH10-05-0328. Epub 2010 Oct 26. Thromb Haemost. 2010. PMID: 20978714
-
[Rivaroxaban: mode of action].Ann Fr Anesth Reanim. 2008 Dec;27 Suppl 3:S9-15. doi: 10.1016/S0750-7658(08)75141-4. Ann Fr Anesth Reanim. 2008. PMID: 19185786 Review. French.
-
The mechanism of action of rivaroxaban--an oral, direct Factor Xa inhibitor--compared with other anticoagulants.Thromb Res. 2011 Jun;127(6):497-504. doi: 10.1016/j.thromres.2010.09.008. Epub 2010 Oct 2. Thromb Res. 2011. PMID: 20888031 Review.
Cited by
-
Thrombelastography detects the anticoagulant effect of rivaroxaban in patients with stroke.Stroke. 2014 Mar;45(3):880-3. doi: 10.1161/STROKEAHA.113.004016. Epub 2014 Jan 14. Stroke. 2014. PMID: 24425115 Free PMC article.
-
Current and future management of pediatric venous thromboembolism.Am J Hematol. 2012 May;87 Suppl 1(0 1):S68-74. doi: 10.1002/ajh.23131. Epub 2012 Feb 24. Am J Hematol. 2012. PMID: 22367975 Free PMC article. Review.
-
A randomized trial of the safety, pharmacokinetics and pharmacodynamics of edoxaban, an oral factor Xa inhibitor, following a switch from warfarin.Br J Clin Pharmacol. 2013 Apr;75(4):966-78. doi: 10.1111/j.1365-2125.2012.04409.x. Br J Clin Pharmacol. 2013. PMID: 22924409 Free PMC article. Clinical Trial.
-
Anticoagulant therapy in pediatrics.J Basic Clin Pharm. 2014 Mar;5(2):27-33. doi: 10.4103/0976-0105.134947. J Basic Clin Pharm. 2014. PMID: 25031496 Free PMC article. Review.
-
The anticoagulant effect of heparin during radiofrequency ablation (RFA) in patients taking apixaban or rivaroxaban.J Interv Card Electrophysiol. 2017 Sep;49(3):237-244. doi: 10.1007/s10840-017-0274-2. Epub 2017 Jul 22. J Interv Card Electrophysiol. 2017. PMID: 28735423
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
